Rare lephants

Screener

NeoGenomics, Inc.

NEO ·Healthcare, Diagnostics & Research, United States

Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation

EPS
Sales Per Share
Book Per Share
FCF Per Share
Dividend Per Share
Shares Outstanding

Share-Based Metrics › Shares Outstanding

← 5Y 10Y MAX →

Shares Outstanding

Fiscal Year	Shares Outstanding
FY2021	120.0M
FY2022	124.2M
FY2023	125.5M
FY2024	126.7M
FY2025	128.1M

About Contact Terms Privacy